United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
25.49B
Market cap25.49B
Price-Earnings ratio
21.12
Price-Earnings ratio21.12
Dividend yield
Dividend yield
Average volume
648.97K
Average volume648.97K
High today
$599.00
High today$599.00
Low today
$571.71
Low today$571.71
Open price
$583.62
Open price$583.62
Volume
318.50K
Volume318.50K
52 Week high
$607.89
52 Week high$607.89
52 Week low
$266.98
52 Week low$266.98

Stock Snapshot

The current United Therapeutics(UTHR) stock price is $581.58, with a market capitalization of 25.49B. The stock trades at a price-to-earnings (P/E) ratio of 21.12.

As of 2026-03-31, United Therapeutics(UTHR) stock has fluctuated between $571.71 and $599.00. The current price stands at $581.58, placing the stock +1.7% above today's low and -2.9% off the high.

United Therapeutics(UTHR) shares are trading with a volume of 318.5K, against a daily average of 648.97K.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $607.89 and a 52-week low of $266.98.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $607.89 and a 52-week low of $266.98.

UTHR News

Nasdaq 7h
United Therapeutics Moves 12.5% Higher: Will This Strength Last?

United Therapeutics (UTHR) shares ended the last trading session 12.5% higher at $588.36. The jump came on an impressive volume with a higher-than-average numbe...

United Therapeutics Moves 12.5% Higher: Will This Strength Last?
TipRanks 1d
What Pushed United Therapeutics Stock Higher Today?

United Therapeutics (UTHR) stock was on the rise Monday after the biotechnology company announced results from its TETON-1 and TETON-2 studies of Tyvaso. These...

TipRanks 1d
United Therapeutics’ Tyvaso Shows Pivotal Success in IPF

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

75%

of 16 ratings
Buy
75%
Hold
25%
Sell
0%

More UTHR News

TipRanks 1d
United Therapeutics announces TETON-1 study met primary efficacy endpoint

United Therapeutics (UTHR) announced that its TETON-1 study evaluating the use of nebulized Tyvaso for the treatment of idiopathic pulmonary fibrosis met its pr...

Investing.com 5d
Rothblatt, United Therapeutics CEO, sells $5.1m in UTHR stock - Investing.com

...

Rothblatt, United Therapeutics CEO, sells $5.1m in UTHR stock - Investing.com
Simply Wall St 6d
Assessing United Therapeutics Valuation As Organ Programs Shape Its 2026 Narrative

Advertisement Why United Therapeutics Is On Investors’ Radar United Therapeutics (UTHR) is drawing attention after a recent move in its share price, with the...

Assessing United Therapeutics Valuation As Organ Programs Shape Its 2026 Narrative

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.